Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
Estrogen receptor-negative breast cancer: new insights into subclassification and targeting
Jean J Zhao, Daniel P Silver
Cancer Discovery
|
July 31, 2012
Mechanisms of BRCA1 tumor suppression
Daniel P Silver, David M Livingston
Current Opinion in Oncology
|
August 27, 2010
Poly ADP-ribose polymerase inhibitors: science and current clinical development
Joyce F Liu, Daniel P Silver
Hematology/Oncology and Stem Cell Therapy
|
April 6, 2023
PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Ranju Kunwor, Daniel P Silver, Maysa Abu-Khalaf
Case Reports in Gastroenterology
|
November 1, 2021
Duodenal and Biliary Obstruction due to Extrinsic CompressionDuodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Case Report
Rukaiya Bashir Hamidu, Bilal Asif, Harish Lavu, et al.
Molecular and Cellular Biology
|
August 6, 2014
BRCA1 pathway function in basal-like breast cancer cells
Sarah J Hill, Allison P Clark, Daniel P Silver, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 7, 2004
Association of BRCA1 with the inactive X chromosome and XIST RNA
Shridar Ganesan, Daniel P Silver, Ronny Drapkin, et al.
Cancer Research
|
May 23, 2002
p16(INK4a) and p53 deficiency cooperate in tumorigenesis
Norman E Sharpless, Scott Alson, Suzanne Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2010
Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer
Carey K Anders, Eric P Winer, James M Ford, et al.
Molecular Cancer Therapeutics
|
February 11, 2026
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
Manish Neupane, Mukesh Kumar, Malela A Mwamufiya, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
Estrogen receptor-negative breast cancer: new insights into subclassification and targeting
Jean J Zhao, Daniel P Silver
Cancer Discovery
|
July 31, 2012
Mechanisms of BRCA1 tumor suppression
Daniel P Silver, David M Livingston
Current Opinion in Oncology
|
August 27, 2010
Poly ADP-ribose polymerase inhibitors: science and current clinical development
Joyce F Liu, Daniel P Silver
Hematology/Oncology and Stem Cell Therapy
|
April 6, 2023
PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Ranju Kunwor, Daniel P Silver, Maysa Abu-Khalaf
Case Reports in Gastroenterology
|
November 1, 2021
Duodenal and Biliary Obstruction due to Extrinsic CompressionDuodenal and Biliary Obstruction due to Extrinsic Compression by Recurrent Lobular Breast Carcinoma: A Case Report
Rukaiya Bashir Hamidu, Bilal Asif, Harish Lavu, et al.
Molecular and Cellular Biology
|
August 6, 2014
BRCA1 pathway function in basal-like breast cancer cells
Sarah J Hill, Allison P Clark, Daniel P Silver, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 7, 2004
Association of BRCA1 with the inactive X chromosome and XIST RNA
Shridar Ganesan, Daniel P Silver, Ronny Drapkin, et al.
Cancer Research
|
May 23, 2002
p16(INK4a) and p53 deficiency cooperate in tumorigenesis
Norman E Sharpless, Scott Alson, Suzanne Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2010
Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer
Carey K Anders, Eric P Winer, James M Ford, et al.
Molecular Cancer Therapeutics
|
February 11, 2026
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy
Manish Neupane, Mukesh Kumar, Malela A Mwamufiya, et al.
Page
of 3